Celldex Therapeutics | CLDX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 444.6B 59.91B 2026-06
Agenus USD 128M 21M 2026-03
Amgen USD 195.44B 5.55B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Celldex Therapeutics USD 2.92B 809M 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Northwest Biotherapeutics USD 332M 24M 2026-03
Pfizer USD 138.44B 15.37B 2026-06
Roche Holding CHF 270B 3.66B 2026-06